Fig. 1

The expression levels of LAG3 in pan-cancer. A TIMER2.0 demonstrated the expression of LAG3 across TCGA cancers and the corresponding normal tissues. B The combination of TCGA and GTEx databases revealed the differential expression of LAG3 in tumor groups compared to normal groups. C The correlation between LAG3 expression and patients’ pathological stages were assessed in TCGA patients. ***p < 0.001; **p < 0.01 and *p < 0.05